Skip to content
healthcare.dev

ZYFLO

NDC 10122-901, zileuton, tablet, from Chiesi USA, Inc..

Product NDC
10122-901
Status
Listed
Labeler
Chiesi USA, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020471
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10122-901 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZILEUTON600 mg/1

Pharmacologic classes

5-Lipoxygenase Inhibitor [EPC]; 5-Lipoxygenase Inhibitors [MoA]; Decreased Leukotriene Production [PE]

Package NDCNDC-11Package
10122-901-1210122090112120 TABLET in 1 BOTTLE (10122-901-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/aee65202-fddb-497f-9f11-17cc727cb157

Use it

Look up 10122-901 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10122-901 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10122-901. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.